SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.67 0.16
(0.19%)

EUR-INR

102.19 -0.14
(-0.14%)

GBP-INR

115.88 -0.12
(-0.10%)

JPY-INR

0.56 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

41.47

819.05

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.11

Back

simplex papers ltd

Shraddha Prime Projects consolidated net profit rises 19.89% in the September 2025 quarter

Nov 16,2025

Net profit of Shraddha Prime Projects rose 19.89% to Rs 8.74 crore in the quarter ended September 2025 as against Rs 7.29 crore during the previous quarter ended September 2024. Sales rose 257.26% to Rs 134.33 crore in the quarter ended September 2025 as against Rs 37.60 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	134.33	37.60	257
OPM %	8.84	26.01	-
PBDT	15.56	10.54	48
PBT	15.53	10.53	47
NP	8.74	7.29	20

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.67 0.16 (0.19%)

102.19 -0.14 (-0.14%)

115.88 -0.12 (-0.10%)

0.56 0.00 (-0.65%)